{"podcast":{"title":"The IMID Forum","slug":"the-imid-forum-981476","podcast_index_feed_id":981476,"rss_url":"https://feeds.soundcloud.com/users/soundcloud:users:176191917/sounds.rss","website_url":"https://imidforum.com/","image_url":"https://i1.sndcdn.com/avatars-OaKRAwW87iY4HNbI-rfRlqw-original.jpg","author":"The Immune-Mediated Inflammatory Disease Forum","episode_count":414,"summary":"Keeping you up to date with the latest and most i…","last_synced_at":"2026-07-30T22:18:23.232091+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476"},"episode":{"title":"Discussing axSpA: Symptom duration impact on bimekizumab efficacy and therapeutic switching drivers","slug":"discussing-axspa-symptom-duration-impact-on-bimekizumab-efficacy-and-therapeutic-switching-drivers","published_at":"2026-03-19T11:00:28+00:00","page_url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-axspa-symptom-duration-impact-on-bimekizumab-efficacy-and-therapeutic-switching-drivers","show_page_url":"https://stenobird.com/podcast/the-imid-forum-981476","url":"https://soundcloud.com/imidforum/discussing-axspa-symptom","audio_url":"https://feeds.soundcloud.com/stream/2286096554-imidforum-discussing-axspa-symptom.mp3","summary":"Join Dr Sofia Ramiro and Dr Atul Dheodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered the impact of shorter versus longer symptom duration on the efficacy of bimekizumab and the factors associated with therapeutic switching in SpA.","meta_description":"Join Dr Sofia Ramiro and Dr Atul Dheodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered the impact of s…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2009,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-axspa-symptom-duration-impact-on-bimekizumab-efficacy-and-therapeutic-switching-drivers/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-imid-forum-981476/discussing-axspa-symptom-duration-impact-on-bimekizumab-efficacy-and-therapeutic-switching-drivers.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}